AstraZeneca and the Hungarian Nephrological Society enter into strategic cooperation
It is estimated that nearly 850 million people worldwide suffer from impaired kidney function and its complications, and all indications are that this will be one of the most threatening diseases in the future. In our country, about one and a half million people can be affected by chronic kidney disease, while depending on their progression, it can increase the risk of cardiovascular damage by up to 14 times.
Related news
Uk medicines authority registers AstraZeneca’s COVID-19 antibody Evusheld
AstraZeneca’s Evusheld has been approved for use by the Medicines…
Read more >U.S. Drug Administration approves long-acting antibody AstraZeneca Evusheld (AZD7442)
AstraZeneca’s Evusheld is a long-acting combination of antibodies (tixagevimab and…
Read more >Related news
Márton Nagy: Domestic consumption is strengthening
Domestic consumption is strengthening, internal demand and the performance of…
Read more >Eurozone inflation accelerated to 2 percent in October
On an annual level, the increase in consumer prices in…
Read more >KSH: in August, the product foreign trade surplus was 443 million euros
In August, the volume of exports decreased by 5.6 percent…
Read more >